Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Non Operating Income (2019 - 2026)

Nkarta (NKTX) posted quarterly Non Operating Income of $3.0 million for Q1 2026, down 33.55% year-over-year from $4.6 million in Q1 2025, and down 14.3% quarter-over-quarter from $3.6 million in Q4 2025.

Nkarta (NKTX) Non Operating Income (2019 - 2026) Analysis & Trends

Nkarta's Non Operating Income history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 33.55% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $16.4 million (down 21.05% YoY), while the FY2025 annual figure was $17.9 million, down 7.68% from the prior year.
  • Non Operating Income for Q1 2026 stood at $3.0 million, down from $3.6 million in the prior quarter.
  • The five-year high for Non Operating Income was $5.7 million in Q2 2024, with the low at $111000.0 in Q1 2022.
  • The 5-year median for Non Operating Income is $3.6 million (2025), against an average of $3.5 million.
  • The sharpest annual moves came in 2022 and 2026: Non Operating Income surged 3189.04% in 2022, then slumped 33.55% in 2026.
  • Nkarta's Non Operating Income stood at $2.4 million in 2022, then soared by 42.9% to $3.4 million in 2023, then soared by 45.38% to $5.0 million in 2024, then decreased by 28.79% to $3.6 million in 2025, then declined by 14.3% to $3.0 million in 2026.
  • Business Quant data shows NKTX's Non Operating Income at $3.0 million in Q1 2026, $3.6 million in Q4 2025, and $5.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -53.64 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -51.63 Mn
10 Nkarta 201.14 Mn 201.14 Mn - 2.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.76 Mn
Mar 31, 2026 3.04 Mn
Dec 31, 2025 3.55 Mn
Sep 30, 2025 5.57 Mn
Jun 30, 2025 4.21 Mn
Mar 31, 2025 4.58 Mn
Dec 31, 2024 4.99 Mn
Sep 30, 2024 5.45 Mn
Jun 30, 2024 5.72 Mn
Mar 31, 2024 3.24 Mn
Dec 31, 2023 3.43 Mn
Sep 30, 2023 3.65 Mn
Jun 30, 2023 3.57 Mn
Mar 31, 2023 3.50 Mn
Dec 31, 2022 2.40 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 689,000.00
Mar 31, 2022 111,000.00
Dec 31, 2021 73,000.00
Sep 30, 2021 75,000.00